Cutaneous lichen planus successfully treated with the Janus kinase-1 inhibitor, abrocitinib

被引：0
|
作者：
Wang, Xi [1 ,2 ]
Wang, Yue [1 ]
Fang, Haoyue [1 ,2 ]
Lin, Mengbi [1 ]
Wang, Fuxi [1 ]
Zhang, Si [1 ]
机构：
[1] Shenzhen Univ, Shenzhen Peoples Hosp 2, Dept Dermatol & Venereol, Affiliated Hosp 1,Hlth Sci Ctr, Shenzhen 518035, Peoples R China
[2] Shenzhen Univ, Postgrad Sch, Hlth Sci Ctr, Shenzhen 518000, Peoples R China
来源：
EUROPEAN JOURNAL OF DERMATOLOGY | 2024年 / 34卷 / 05期
关键词：
D O I：
10.1684/ejd.2024.4770
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：557 / 559
页数：3
相关论文
共 50 条
  • [41] Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis A Phase 2 Randomized Clinical Trial
    Gooderham, Melinda J.
    Forman, Seth B.
    Bissonnette, Robert
    Beebe, Jean S.
    Zhang, Weidong
    Banfield, Chris
    Zhu, Linda
    Papacharalambous, Jocelyne
    Vincent, Michael S.
    Peeva, Elena
    JAMA DERMATOLOGY, 2019, 155 (12) : 1371 - 1379
  • [42] Refractory case of ulcerative colitis with idiopathic thrombocytopenic purpura successfully treated by Janus kinase inhibitor tofacitinib: A case report
    Komeda, Yoriaki
    Sakurai, Toshiharu
    Sakai, Kazuko
    Morita, Yasuyoshi
    Hashimoto, Arito
    Nagai, Tomoyuki
    Hagiwara, Satoru
    Matsumura, Itaru
    Nishio, Kazuto
    Kudo, Masatoshi
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (24)
  • [43] Refractory case of ulcerative colitis with idiopathic thrombocytopenic purpura successfully treated by Janus kinase inhibitor tofacitinib:A case report
    Yoriaki Komeda
    Toshiharu Sakurai
    Kazuko Sakai
    Yasuyoshi Morita
    Arito Hashimoto
    Tomoyuki Nagai
    Satoru Hagiwara
    Itaru Matsumura
    Kazuto Nishio
    Masatoshi Kudo
    World Journal of Clinical Cases, 2020, (24) : 6389 - 6395
  • [44] ANNULAR LICHEN PLANUS ON PENIS TREATED WITH TOPICAL PIMECROLIMUS 1%
    Natasatsekova
    Krasnaliev, I.
    Bakardjiev, I.
    Miteva, L.
    Pehlivanov, G.
    SEXUALLY TRANSMITTED INFECTIONS, 2017, 93 : A82 - A82
  • [45] Ruxolitinib: An Oral Janus Kinase 1 and Janus Kinase 2 Inhibitor in the Management of Myelofibrosis
    Verstovsek, Srdan
    POSTGRADUATE MEDICINE, 2013, 125 (01) : 128 - 135
  • [46] Predictors of maintenance of response in patients with moderate to severe atopic dermatitis after oral Janus kinase 1 selective inhibitor abrocitinib interruption
    Gooderham, Melinda J.
    Girolomoni, Giampiero
    Moore, Julian O'Neil
    Silverberg, Jonathan I.
    Curto, Madelyn
    Zhang, Weidong
    DiBonaventura, Marco
    Valdez, Hernan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB64 - AB64
  • [47] Lichen planus pemphigoides erupting after COVID-19 vaccination and infection, successfully treated with methotrexate
    Andren, Josefin
    Vassilaki, Ismini
    Curman, Philip
    JEADV CLINICAL PRACTICE, 2024, 3 (02): : 714 - 717
  • [48] Pediatric case of lichen planus pigmentosus inversus successfully treated with narrow band ultraviolet B phototherapy
    Dimova, Maja
    Damevska, Katerina
    Nikolovska, Suzana
    Dohcheva-Karajovanov, Ivana
    Duma, Silvija
    Kostovski, Marko
    Simeonovski, Viktor
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [49] Janus kinase inhibitor tofacitinib successfully treated palmoplantar pustulosis after switching from secukinumab: A case report and review of the literature
    Fan, Yiming
    Yin, Rui
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 139
  • [50] Aldehyde Dehydrogenase Isoform 1 as an Indicator in the Malignant Potential of Cutaneous Lichen Planus
    Aliakbarpour, Fatemeh
    Alijanpour, Robabeh
    Ghorbani, Raheb
    Bisheh, Saba Gilaki
    Kashfi, Arezoo
    Sohanian, Shabnam
    JOURNAL OF THE SCIENTIFIC SOCIETY, 2023, 50 (02) : 182 - 187
12345